While no semaglutide-specific guidelines exist for kidney stone prevention, general nephrology principles apply, with particular attention to treatment-related considerations
The STEP trials assessed the efficacy and safety of semaglutide 2.4 mg in individuals with overweight (BMI 27.0 kg/m with at least one weight-related comorbidity) or obesity (BMI 30.0 kg/m), both with and without T2D or prediabetes
Eshdat Y, Holland D, Faltin Z, Ben-Hayyim G (1997) Plant glutathione peroxidases
Hernandez AF, Green JB, Janmohamed S, et al
Present your CharityRx discount card or coupon to the pharmacist and receive instant savings of up to 80%
Regardless of age, from college student to senior citizen, all of us experience brain fog from time to time